Publication:
Changes in the etiology of chronic liver disease by referral to a fibroscan center: rising prevalence of the non-alcoholic fatty liver disease” hepatology

dc.contributor.authorÖZEL, FURKAN
dc.contributor.authorLÜLECİ, NİMET EMEL
dc.contributor.authorsEris T., Hassan M., Hikal Y., Sawah E., Daneshgar F., TEKER SAYIN A. G., ÖZEL F., LÜLECİ N. E., Kaya E., YILMAZ Y.
dc.date.accessioned2022-12-28T12:43:15Z
dc.date.available2022-12-28T12:43:15Z
dc.date.issued2022-12-01
dc.description.abstractBackground and Aim: Chronic liver disease (CLD) is a leading cause of morbidity and mortality worldwide with wide etiological spectrum. FibroScan® is used for follow-up of fibrosis and steatosis. This single center study aims to review the distribution of indications by referral to FibroScan®. Materials and Methods: Demographic characteristics, CLD etiologies, and FibroScan® parameters of the patients, who were referred to our tertiary care center between 2013 and 2021 were retrospectively evaluated. Results: Out of 9,345 patients, 4,946 (52.9%) were male, and median age was 48 [18-88]. Nonalcoholic fatty liver disease (NAFLD) was the most common indication (N= 4,768, 51.02%) followed by hepatitis B (N=3,194, 34.18%) and hepatitis C (N=707, 7.57%). Adjusting for age, sex, CLD etiology, the results revealed that patients with older age (Odds ratio (OR) =2.908, confidence interval (CI): 2.597-3.256, P<0.001), and patients with hepatitis C (OR= 2.582; CI=2.168-3.075; P<0.001), alcoholic liver disease (OR=2.019; CI=1.524-2.674, P<0.001), autoimmune hepatitis (OR=2.138; CI=1.360-3.660, P<0.001) had increased odds of advanced liver fibrosis compared to NAFLD. Conclusion: NAFLD was the most common indication for referral to FibroScan®.
dc.identifier.citationEris T., Hassan M., Hikal Y., Sawah E., Daneshgar F., TEKER SAYIN A. G., ÖZEL F., LÜLECİ N. E., Kaya E., YILMAZ Y., "Changes in the Etiology of Chronic Liver Disease by Referral to a Fibroscan Center: Rising Prevalence of the Non-Alcoholic Fatty Liver Disease” Hepatology", Hepatology Forum, cilt.3, sa.3, 2022
dc.identifier.doi10.14744/hf.2022.2022.0042
dc.identifier.endpage27
dc.identifier.issn1307-5888
dc.identifier.issue3
dc.identifier.startpage1
dc.identifier.urihttps://hepatologyforum.org/storage/upload/pdfs/1670335961-en.pdf
dc.identifier.urihttps://hdl.handle.net/11424/284496
dc.identifier.volume3
dc.language.isoeng
dc.relation.ispartofHepatology Forum
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectChronic Liver Disease
dc.subjectIndications
dc.subjectLiver Fibrosis
dc.titleChanges in the etiology of chronic liver disease by referral to a fibroscan center: rising prevalence of the non-alcoholic fatty liver disease” hepatology
dc.typearticle
dspace.entity.typePublication
local.avesis.idfe2aab8e-020f-4bc6-ae58-32f7e83d3185
relation.isAuthorOfPublicationc6d65b27-1039-440e-b83e-62e70558bdb1
relation.isAuthorOfPublication54522026-6a5e-4365-9ed6-edc24c702b69
relation.isAuthorOfPublication.latestForDiscoveryc6d65b27-1039-440e-b83e-62e70558bdb1

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
21.pdf
Size:
1.17 MB
Format:
Adobe Portable Document Format

Collections